Patients were randomly assigned to NPLD ( M , @ mg/m ( @ ) every @ weeks for six cycles ) , trastuzumab ( T , @ mg/kg loading dose followed by @ mg/kg weekly ) , and paclitaxel ( P , @ mg/m ( @ ) weekly ) or T + P at the same doses until progression or toxicity .